GRRPX
Price
$9.46
Change
-$0.01 (-0.11%)
Updated
Jun 18 closing price
Net Assets
2.36B
RNWBX
Price
$81.73
Change
-$0.08 (-0.10%)
Updated
Jun 18 closing price
Net Assets
67.7B
Interact to see
Advertisement

GRRPX vs RNWBX

Header iconGRRPX vs RNWBX Comparison
Open Charts GRRPX vs RNWBXBanner chart's image
Goldman Sachs Em Mkts Eq Insghts R
Price$9.46
Change-$0.01 (-0.11%)
VolumeN/A
Net Assets2.36B
American Funds New World R2
Price$81.73
Change-$0.08 (-0.10%)
VolumeN/A
Net Assets67.7B
GRRPX vs RNWBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GRRPX vs. RNWBX commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRRPX is a Hold and RNWBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWBX has more cash in the bank: 67.7B vs. GRRPX (2.36B). GRRPX pays higher dividends than RNWBX: GRRPX (0.72) vs RNWBX (0.13). GRRPX was incepted earlier than RNWBX: GRRPX (11 years) vs RNWBX (23 years). GRRPX (1.76) is less costly to investors than RNWBX (1.67). GRRPX is a more actively managed with annual turnover of: 168.00 vs. RNWBX (37.00). GRRPX has a lower initial minimum investment than RNWBX: GRRPX (0) vs RNWBX (250). GRRPX annual gain was more profitable for investors over the last year : 8.69 vs. RNWBX (6.46). RNWBX return over 5 years is better than : 25.50 vs. GRRPX (17.67).
GRRPXRNWBXGRRPX / RNWBX
Total Expense Ratio1.591.6795%
Annual Report Gross Expense Ratio1.761.67105%
Fund Existence11 years23 years-
Gain YTD11.54311.122104%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.36B67.7B3%
Annual Yield % from dividends0.720.13537%
Returns for 1 year8.696.46135%
Returns for 3 years24.8233.6074%
Returns for 5 years17.6725.5069%
Returns for 10 years21.6653.2141%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IMVT15.860.55
+3.59%
Immunovant
SLXN0.820.01
+1.77%
Silexion Therapeutics Corp
WWD238.992.42
+1.02%
Woodward
FONR14.06-0.02
-0.14%
Fonar Corp
FIP6.51-0.01
-0.15%
FTAI Infrastructure